-+ 0.00%
-+ 0.00%
-+ 0.00%
Baiyunshan (00874): A wholly-owned subsidiary plans to participate in the investment of Walbo Capital Health Limited Partnership Fund
Share
Listen to the news

According to Zhitong Finance App, Baiyunshan (00874) announced that Guangyao Baiyunshan Hong Kong Co., Ltd. (“Baiyunshan Hong Kong”), a wholly-owned subsidiary of the company, plans to invest HK$350 million to pledge the limited partnership share of the Walbo Capital Health Limited Partnership Fund (“Asia Health Fund”), accounting for 35% of the fund after the fundraising is completed.

In order to implement the company's international development strategy and develop overseas expansion with superior resources such as industry, channels, and information of the Walgreens Boots Alliance (“Wobble”), the company's wholly-owned subsidiary Baiyunshan Hong Kong plans to establish an Asian Health Fund in cooperation with Walgreens Asia Investment Limited (formerly known as Alliance Healthcare Asia Pacific Limited, “AHAPL”). Jointly invest in the layout of the Asian healthcare industry.

Asia Health Fund intends to register in Hong Kong, China, with a target size of HK$1.0 billion. Walbo Capital Health General Partnership Limited (“Wobo Health”) is the general partner of the fund, and AHAPL designator Well Equity Asia Wellness LP Fund (“AHAPL Fund”) and Baiyunshan Hong Kong are the fund anchoring limited partners to separately subscribe for HK$350 million limited partnership shares, and the remaining HK$300 million limited partnership shares are raised privately from other financial investors .

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending